[go: up one dir, main page]

SE8704185L - Nya peptider, artificiella antigener och immunoanalystestsatser - Google Patents

Nya peptider, artificiella antigener och immunoanalystestsatser

Info

Publication number
SE8704185L
SE8704185L SE8704185A SE8704185A SE8704185L SE 8704185 L SE8704185 L SE 8704185L SE 8704185 A SE8704185 A SE 8704185A SE 8704185 A SE8704185 A SE 8704185A SE 8704185 L SE8704185 L SE 8704185L
Authority
SE
Sweden
Prior art keywords
pct
antigen
artificial
hiv
analysis test
Prior art date
Application number
SE8704185A
Other languages
English (en)
Other versions
SE8704185D0 (sv
Inventor
Jerzy Trojnar
Brita Wahren
Ulla Ruden
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20370026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8704185(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8704185A priority Critical patent/SE8704185L/sv
Publication of SE8704185D0 publication Critical patent/SE8704185D0/sv
Priority to JP63508893A priority patent/JP2818797B2/ja
Priority to AU26242/88A priority patent/AU627701B2/en
Priority to EP88909626A priority patent/EP0396559B1/en
Priority to FI902143A priority patent/FI902143A0/fi
Priority to AT88909626T priority patent/ATE141286T1/de
Priority to DE3855479T priority patent/DE3855479T2/de
Priority to US07/473,994 priority patent/US5981170A/en
Priority to PCT/SE1988/000570 priority patent/WO1989003844A1/en
Priority to IL88224A priority patent/IL88224A0/xx
Publication of SE8704185L publication Critical patent/SE8704185L/sv
Priority to NO901899A priority patent/NO302369B1/no
Priority to DK104590A priority patent/DK104590A/da
Priority to JP20944197A priority patent/JP3231666B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8704185A 1987-10-28 1987-10-28 Nya peptider, artificiella antigener och immunoanalystestsatser SE8704185L (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8704185A SE8704185L (sv) 1987-10-28 1987-10-28 Nya peptider, artificiella antigener och immunoanalystestsatser
PCT/SE1988/000570 WO1989003844A1 (en) 1987-10-28 1988-10-27 Hiv peptides, artificial hiv antigens and immunoassay kits
US07/473,994 US5981170A (en) 1987-10-28 1988-10-27 Peptides, artificial antigens and immunoassay kits
AT88909626T ATE141286T1 (de) 1987-10-28 1988-10-27 Hiv-peptide, künstliche hiv-antigene und immuntestsätze
AU26242/88A AU627701B2 (en) 1987-10-28 1988-10-27 Hiv peptides, artificial hiv antigens and immunoassay kits
EP88909626A EP0396559B1 (en) 1987-10-28 1988-10-27 Hiv peptides, artificial hiv antigens and immunoassay kits
FI902143A FI902143A0 (fi) 1987-10-28 1988-10-27 Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar.
JP63508893A JP2818797B2 (ja) 1987-10-28 1988-10-27 新ペプチド、人工抗原およびイムノアッセイキット
DE3855479T DE3855479T2 (de) 1987-10-28 1988-10-27 Hiv-peptide, künstliche hiv-antigene und immuntestsätze
IL88224A IL88224A0 (en) 1987-10-28 1988-10-28 Peptides,artificial antigens and immunoassay kits
NO901899A NO302369B1 (no) 1987-10-28 1990-04-27 HIV-peptider og anvendelse derav, syntetiske HIV-antigener og diagnostisk immunoanalysesett
DK104590A DK104590A (da) 1987-10-28 1990-04-27 Hiv-peptider, kunstige hiv-antigener og immunoassay
JP20944197A JP3231666B2 (ja) 1987-10-28 1997-08-04 新ペプチド、人工抗原およびイムノアッセイキット

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704185A SE8704185L (sv) 1987-10-28 1987-10-28 Nya peptider, artificiella antigener och immunoanalystestsatser

Publications (2)

Publication Number Publication Date
SE8704185D0 SE8704185D0 (sv) 1987-10-28
SE8704185L true SE8704185L (sv) 1989-04-29

Family

ID=20370026

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704185A SE8704185L (sv) 1987-10-28 1987-10-28 Nya peptider, artificiella antigener och immunoanalystestsatser

Country Status (11)

Country Link
US (1) US5981170A (sv)
EP (1) EP0396559B1 (sv)
JP (2) JP2818797B2 (sv)
AT (1) ATE141286T1 (sv)
DE (1) DE3855479T2 (sv)
DK (1) DK104590A (sv)
FI (1) FI902143A0 (sv)
IL (1) IL88224A0 (sv)
NO (1) NO302369B1 (sv)
SE (1) SE8704185L (sv)
WO (1) WO1989003844A1 (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128319A (en) * 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
JPH05506221A (ja) * 1990-04-03 1993-09-16 ジェネンテク，インコーポレイテッド Ｈｉｖエンベロープポリペプチド
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
WO2000029008A2 (en) 1998-11-16 2000-05-25 Board Of Regents, The University Of Texas System Hiv-specific t-cell induction
US6962982B2 (en) 2001-06-22 2005-11-08 Roche Diagnostics Corporation Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
US7094757B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them
ES2372031T3 (es) 2001-06-22 2012-01-13 F. Hoffmann-La Roche Ag Complejo soluble que contiene una glicoproteína de superficie retroviral y fkpa o slyd.
US7094884B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
US7615530B2 (en) * 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
EP1681568A1 (en) * 2003-10-29 2006-07-19 Hidechika Okada Artificial antibody comprising complementary peptide
CN101296945A (zh) * 2005-10-25 2008-10-29 人工细胞技术公司 免疫原性组合物及其使用方法
US7723294B2 (en) * 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
EP3187585A1 (en) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
EP0220273B2 (en) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetic antigens for the detection of aids-related disease
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
WO1987006005A1 (en) * 1986-03-24 1987-10-08 Ortho Pharmaceutical Corporation Synthetic htlv-iii peptides, compositions and uses thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4957737A (en) * 1986-05-27 1990-09-18 Hoffmann-La Roche Inc. HTLV-III (LAV) envelope peptides
EP0247557B1 (en) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV) Envelope peptides
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern

Also Published As

Publication number Publication date
JP3231666B2 (ja) 2001-11-26
DK104590D0 (da) 1990-04-27
NO302369B1 (no) 1998-02-23
SE8704185D0 (sv) 1987-10-28
DK104590A (da) 1990-06-26
IL88224A0 (en) 1989-06-30
WO1989003844A1 (en) 1989-05-05
NO901899D0 (no) 1990-04-27
JP2818797B2 (ja) 1998-10-30
ATE141286T1 (de) 1996-08-15
EP0396559A1 (en) 1990-11-14
DE3855479T2 (de) 1997-01-02
JPH03500648A (ja) 1991-02-14
DE3855479D1 (de) 1996-09-19
EP0396559B1 (en) 1996-08-14
JPH10101697A (ja) 1998-04-21
NO901899L (no) 1990-04-27
US5981170A (en) 1999-11-09
FI902143A7 (sv) 1990-04-27
FI902143A0 (fi) 1990-04-27

Similar Documents

Publication Publication Date Title
SE8704185L (sv) Nya peptider, artificiella antigener och immunoanalystestsatser
ES2064316T3 (es) Composicion de peptido y procedimiento para la deteccion de anticuerpos frente al htlv-iii.
ATE375516T1 (de) Immuntest zur messung des humanen c-peptides sowie reagenzienkit hierfür
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
FI84107C (sv) HbA1c:s immunologiska bestämningsförfarande som innefattar denaturerin g
DE68923882D1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
ATE140540T1 (de) Verfahren zur zurichtung eines verbesserten western-blott-immuntestverfahrens
Child et al. A review of the applications of immunochemistry to archaeological bone
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
SE9000595D0 (sv) New peptides, diagnostic antigens and an immunoassay method
KR920702688A (ko) Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로 부터 유도된 항체
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
DE69015708D1 (de) Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.
ATE143673T1 (de) Testverfahren von glykosylierten proteinen unter verwendung eines antikörpers gerichtet gegen reduzierte glykosylierte n-terminal-aminosäuren
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
FI913714A0 (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
KR910007962A (ko) Hiv 관련 펩티드
DK312088A (da) Hidtil ukendte peptider og anvendelser deraf
ES2113860T3 (es) Peptidos con grupos tioles de cisteina protegidos, utiles en los ensayos inmunologicos.
EP0985931A3 (en) Recombinant antigen immunoassay for the diagnosis of syphilis
ATE138078T1 (de) Analysemethode für infektiöse pferdeanämie-viren (eia-virus)
Winsnes Quantification of Tetanus Antitoxin in Human Sera: I. Counter‐Immunoelectrophoresis
Oliver et al. Autoantibodies to the cytoskeleton in human sera
JPS6490197A (en) Peptide

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8704185-1

Effective date: 19900602